eFFECTOR Therapeutics Inc. Gains 37.62%
Tue, Jun 06, 2023 at 07:42 PM
eFFECTOR Therapeutics Inc. (EFTR:NASDAQ) rocketted at $1.39, representing a gain of 37.6%. On Tue, Jun 06, 2023, EFTR:NASDAQ touched a New 2-Week High of $1.39. The stock appeared on our News Catalysts scanner on Thu, May 25, 2023 at 06:17 PM in the 'BIOTECH' category. From Tue, May 23, 2023, the stock recorded 77.78% Up Days and 60.00% Green Days
About eFFECTOR Therapeutics Inc. (EFTR:NASDAQ)
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer.
Top 10 Gainers:
- Hoth Therapeutics, Inc. (HOTH:NASDAQ), 78.19%
- AgriFORCE Growing Systems Ltd. (AGRI:NASDAQ), 64.67%
- Beamr Imaging Ltd. (BMR:NASDAQ), 49.07%
- eFFECTOR Therapeutics Inc. (EFTR:NASDAQ), 37.62%
- Faraday Future Intelligent Electric Inc. (FFIE:NASDAQ), 31.46%
- GitLab Inc. (GTLB:NASDAQ), 31.19%
- MicroVision, Inc. (MVIS:NASDAQ), 30.39%
- MedAvail Holdings Inc. (MDVL:NASDAQ), 30.17%
- G-III Apparel Group, Ltd. (GIII:NASDAQ), 28%
- Synlogic, Inc. (SYBX:NASDAQ), 27.46%